0001192482-16-000483.txt : 20160122
0001192482-16-000483.hdr.sgml : 20160122
20160122175522
ACCESSION NUMBER: 0001192482-16-000483
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160120
FILED AS OF DATE: 20160122
DATE AS OF CHANGE: 20160122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duke Barry S
CENTRAL INDEX KEY: 0001640699
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 161357129
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-01-20
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001640699
Duke Barry S
780 DEDHAM STREET, SUITE 800
CANTON
MA
02021
0
1
0
0
See remarks
Common Stock
2016-01-20
4
A
0
4913
0
A
4913
D
Stock Option (Right to Purchase)
16.15
2016-01-20
4
A
0
29475
0
A
2026-01-20
Common Stock
29475
29475
D
Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on January 20, 2016. Twenty-five percent (25%) of the restricted stock units vest on January 20, 2017, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock.
The option vests and becomes exercisable over a four-year period commencing on January 20, 2016. Twenty-five percent (25%) of the option vests and becomes exercisable on January 20, 2017, and the balance vests in equal monthly installments (rounded up to the nearest whole share) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer.
Executive Vice President and Chief Commercial Officer
/s/ Paul Brannelly as Attorney-In-Fact For Barry S. Duke
2016-01-22